Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Test@Work Study: Evaluation of Attitudes and Uptake Within Employee Health Checks in the Construction Industry (Test@Work)

13. september 2021 oppdatert av: Holly Blake, University of Nottingham

Test@Work: Evaluation of Attitudes and Uptake Within Employee Health Checks in the Construction Industry

This project is called Test@Work. In this project the investigators will offer general health checks and tailored health advice to up to 650 employees in the construction industry at sites across the East Midlands. The investigators will assess reach and uptake, and evaluate the views and perceptions of employees, managers and the delivery team. Health checks will include Body Mass Index (BMI; weight/height), waist-to-hip ratio, blood pressure, mental health screen, sexual health consultation and an opt-in rapid screening test for human immunodeficiency virus (HIV). Employees will be provided with a resource pack with information and signposting around physical activity, diabetes risk, diet, and musculoskeletal health. A digital resource providing information and signposting about workplace health screening and HIV testing will be developed and provided to managers at the participating worksites 2 weeks before their health check event.

Employees will be offered an additional text messaging service involving receipt of a series of messages with advice around HIV and testing alongside general health information. Employees will complete post-health check exit questionnaires and an exit interview. Managers will complete a post-event evaluation questionnaire and post-event interview. Mixed-methods evaluation will include assessment of reach, uptake, and intervention implementation processes.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

The investigators will collect evaluation data with employees and company representatives.

Employees: will complete exit-questionnaires and be invited to a brief exit interview.

The investigators will collect by anonymous questionnaire: age, gender, country of birth, ethnicity, postcode, sexual orientation, employment status (FT/PT, permanent, agency, contract worker), reasons for attending, health perceptions, prior HIV testing history, influence of work on health, perceptions of employers provision for health and wellbeing, perceptions towards HIV testing in the workplace, range of tests undertaken, views about the workplace health check and future health intentions. Personal identifiers will not be collected and questionnaire data will not be provided to employers. Those employees who agree to be interviewed after the health check will be invited to a brief independent confidential interview with the project researcher.

Company representatives: will complete brief post-event questionnaire and be invited to post-event interview

The investigators will ask about the organisational/employee profile, their perceptions of company provision for health and wellbeing, perceptions towards the usefulness of the implementation toolkit and towards HIV testing in the workplace, method of delivery and their confidence to support employees who disclose a positive test outcome, views about the workplace health check and future implementation intentions.

Studietype

Intervensjonell

Registrering (Faktiske)

456

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Nottingham, Storbritannia, NG72HA
        • University of Nottingham

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • employee of a company in construction or related industries
  • provides informed consent

Exclusion Criteria:

  • does not speak English

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Health Checks
Workplace health checks - in this intervention employees can select from a range of optional health checks/tests and receive tailored health advice and a health resource pack.
Offer of a general health check including opt-in sexual health consultation and HIV testing, weight/height, Body Mass Index (BMI), blood pressure, mental health screen. Provision of tailored health advice and a resource pack with information and signposting.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Health check uptake
Tidsramme: Rolling intervention delivery and data collection over 15 months
Percentage of employees choosing to take a workplace health check from total employee population across all sites
Rolling intervention delivery and data collection over 15 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
reasons for attending
Tidsramme: immediately post-event
Qualitative data collected on reasons for opting in to health check
immediately post-event
perceptions of employer's provision for health and wellbeing
Tidsramme: immediately post-event
Qualitative data collected on perceptions towards employer
immediately post-event
perceptions towards HIV testing in the workplace
Tidsramme: immediately post-event
Qualitative data collected on employee views towards HIV testing at work
immediately post-event
range of tests undertaken
Tidsramme: during the health check, and qualitative data immediately post-event
which of the optional checks/tests were taken by the employee
during the health check, and qualitative data immediately post-event
Employee demographic profile
Tidsramme: At recruitment
Age, Gender, country of birth, ethnicity, postcode, sexual orientation, employment status (full-time or part-time, permanent, agency, contract worker)
At recruitment

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Hjelpsomme linker

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

17. august 2019

Primær fullføring (Faktiske)

30. november 2020

Studiet fullført (Faktiske)

31. mai 2021

Datoer for studieregistrering

Først innsendt

6. desember 2019

Først innsendt som oppfylte QC-kriteriene

28. februar 2020

Først lagt ut (Faktiske)

2. mars 2020

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

20. september 2021

Siste oppdatering sendt inn som oppfylte QC-kriteriene

13. september 2021

Sist bekreftet

1. september 2021

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • IN-UK-276-5347 HIV DVE

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

The investigators are not collecting individual health outcomes as part of this study. The primary aim is to assess uptake and reach of this workplace health checks initiative. Anonymised qualitative data can be available on reasonable request.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på HIV

Kliniske studier på Test@Work

Abonnere